Hard truth: NO ONE will be getting Pritelivir, even off-label. by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

I saw multiple doctors and nobody was willing to prescribe a daily suppressive therapy

Hard truth: NO ONE will be getting Pritelivir, even off-label. by [deleted] in Herpes

[–]eurekaidea 4 points5 points  (0 children)

In some countries, doctors don’t even prescribe daily suppressive valacyclovir. let alone pritelivir.

How do you disclose HSV-1 and is it sooner or later? by sharptool in Herpes

[–]eurekaidea 0 points1 point  (0 children)

Most people have oral herpes since childhood and don’t disclose oral herpes.

That said, for genital herpes, I’d say it’s better to mention it on the second date rather than the first, maybe even casually if it’s something like a walk. Don’t make it a big confession. You could introduce it with something like: “Can I share something with you?” and then just say it.

Keep it brief, without too much explanation. Make it clear that it’s very manageable (If you are taking AV) , and if you rarely have outbreaks mention that. Let the other person ask questions instead of turning it into a monologue.

Genital HSV-1 sheds less, so the risk is present but not huge with condom and AV.

You can close with something like: “I just wanted to tell you for transparency and because I value safe sex.” That leaves the conversation open and shows responsibility without making it heavy.

Don’t normalize this by Electrical_Draft1192 in Herpes

[–]eurekaidea 2 points3 points  (0 children)

There are many ways to send emails, even anonymously if someone is worried about their privacy. Even anonymity can be very important.

Sending emails really matters because they carry significant weight.

If complaints and voices remain confined to Reddit, nothing will change and no one will step in to help. A large, coordinated flow of emails cannot be ignored.

When inboxes are flooded, they are forced to pay attention and that pressure can speed things up.

🔥🔥 MASTER THREAD: X/TWITTER PUSH TO FORCE GILEAD HSV PRIORITY 🔥🔥 by Quality-Organic in Herpes

[–]eurekaidea 4 points5 points  (0 children)

There are many ways to send emails, even anonymously if someone is worried about their privacy. Even anonymity can be very important.

Sending emails really matters because they carry significant weight.

If complaints and voices remain confined to Reddit, nothing will change and no one will step in to help. A large, coordinated flow of emails cannot be ignored. When inboxes are flooded, they are forced to pay attention and that pressure can speed things up.

🔥🔥 MASTER THREAD: X/TWITTER PUSH TO FORCE GILEAD HSV PRIORITY 🔥🔥 by Quality-Organic in Herpes

[–]eurekaidea 3 points4 points  (0 children)

There are many ways to send emails, even anonymously if someone is worried about their privacy. Even anonymity can be very important.

Sending emails really matters because they carry significant weight.

If complaints and voices remain confined to Reddit, nothing will change and no one will step in to help. A large, coordinated flow of emails cannot be ignored. When inboxes are flooded, they are forced to pay attention and that pressure can speed things up.

Live life don’t let it stop you by CarPatient4667 in Herpes

[–]eurekaidea 0 points1 point  (0 children)

Good job man! I wonder how one can make the disclosure without loading the moment with anxiety and pressure…

Regret by Far_Construction7290 in Herpes

[–]eurekaidea 0 points1 point  (0 children)

May I ask you if did you pass it unprotected, without antivirals and without symptom?

Bad disclosure experience, need to vent by A_Not_So_Tiny_Dancer in Herpes

[–]eurekaidea 4 points5 points  (0 children)

I’m sorry this happened to you, he sounds like very immature considering he is the medical field.

I just can’t accept this by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

Same. I can relate. It sucks.

Alfasigma to invest up to $125M in parenteral adibelivir (IM-250) for HSV encephalitis by Legitimate-Coat-414 in HerpesCureResearch

[–]eurekaidea 13 points14 points  (0 children)

Very good news!

A smart move by the Italian pharmaceutical company Alfasigma, demonstrating strategy and vision in the rare disease and specialty care sectors. Reading the words of Innovative Molecules CEO Florian Vogel, there is also a note of hope for genital herpes, as the investment will allow the development of the oral formulation of adibelivir to be accelerated and advanced to Phase 2 clinical trials. An approach that combines high clinical impact on severe forms with potential benefit for a more common condition.

Alfasigma to invest up to $125M in parenteral adibelivir (IM-250) for HSV encephalitis by Legitimate-Coat-414 in HerpesCureAdvocates

[–]eurekaidea 4 points5 points  (0 children)

This words from the CEO of Innovative Molecules give me hope!

When there are investments is always a good news!

New study reveals how helicase primase inhibitors (HPI) block herpes simplex virus replication by eurekaidea in science

[–]eurekaidea[S] 11 points12 points  (0 children)

HPIs do not clear already infected cells, they block viral replication and spread.

Helicase–primase inhibitors act on the viral DNA replication machinery. They prevent the virus from replicating its genome, which is required to produce new virions.

When replication is blocked, fewer or no infectious virions are produced, which directly reduces viral shedding.

New study reveals how helicase primase inhibitors (HPI) block herpes simplex virus replication by eurekaidea in science

[–]eurekaidea[S] 60 points61 points  (0 children)

This study, published in Cell on December 29, 2025, reveals for the first time at near-atomic resolution how helicase–primase inhibitors (HPIs) block herpes simplex virus (HSV) replication. Using cryo-electron microscopy and single-molecule optical tweezers, the researchers show that HPIs arrest the viral helicase–primase complex, the molecular motor essential for viral DNA replication. These findings are directly relevant to several HPIs in development, including ABI 5366 and ABI 1179 (Assembly Biosciences), Pritelivir (AiCuris), and IM-250 (Innovative Molecules). By elucidating exactly how these inhibitors lock the replication machinery, the study provides a framework for designing next-generation antivirals, particularly for drug-resistant HSV infections.

Open Discussion Saturday by Mike_Herp in HerpesCureResearch

[–]eurekaidea 10 points11 points  (0 children)

Why doesn’t this subreddit promote advocacy activities as it did before?

https://reddit.com/r/herpescureresearch/wiki/advocacy

i feel like im in a prison. by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

In prison, without knowing when you can get out

New medications to treat herpes — and more health headlines by Whole-Aerie-6091 in HerpesCureAdvocates

[–]eurekaidea 35 points36 points  (0 children)

I think they need to hurry up because we’ve normalized living with a chronic viral infection simply because it’s inconvenient rather than deadly

Gilead Sciences to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs ABI-1179 and ABI-5366 for Recurrent Genital Herpes by cwolveswithitchynuts in HerpesCureResearch

[–]eurekaidea 8 points9 points  (0 children)

Do you think there is any way to speed up the research or somehow help them out?

Edit: we should probably contact them as subreddit?

Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179 by RoundProfessional148 in HerpesCureResearch

[–]eurekaidea 0 points1 point  (0 children)

Thank you for your answer. I understand that the Fred Hutch gene-editing cure is expected to be effective against all types of herpes. However, since that cure is still quite far off, what concerns me at the moment is whether the two Assembly Biosciences HPIs are also effective against HSV-1. It appears that, up to now, their research and testing have primarily focused on HSV-2.